HUMAN IMMUNOGLOBULIN G\HYALURONIDASE for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 881 adverse event reports in the FDA FAERS database where HUMAN IMMUNOGLOBULIN G\HYALURONIDASE was used for Immunodeficiency common variable.
Most Reported Side Effects for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Inappropriate schedule of product administration | 610 | 20.8% | 34 | 273 |
| Covid-19 | 524 | 17.9% | 23 | 246 |
| Pneumonia | 474 | 16.2% | 36 | 308 |
| Sinusitis | 453 | 15.5% | 6 | 192 |
| Fatigue | 448 | 15.3% | 16 | 193 |
| Headache | 395 | 13.5% | 9 | 174 |
| Product dose omission issue | 378 | 12.9% | 15 | 192 |
| Malaise | 323 | 11.0% | 16 | 160 |
| Pyrexia | 316 | 10.8% | 23 | 197 |
| Infusion site erythema | 312 | 10.7% | 19 | 103 |
| Infusion site pain | 285 | 9.7% | 9 | 104 |
| Infection | 261 | 8.9% | 13 | 136 |
| Illness | 255 | 8.7% | 9 | 115 |
| Insurance issue | 253 | 8.6% | 3 | 117 |
| Pain | 250 | 8.5% | 6 | 120 |
Other Indications for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
Primary immunodeficiency syndrome (1,170)
Secondary immunodeficiency (442)
Immunodeficiency (404)
Product used for unknown indication (267)
Hypogammaglobulinaemia (126)
Chronic inflammatory demyelinating polyradiculoneuropathy (88)
Immune system disorder (51)
Plasma cell myeloma (49)
Selective igg subclass deficiency (46)
Hypergammaglobulinaemia (38)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)
MYCOPHENOLATE MOFETIL (24)